The Misuse of Drugs (Designation) (Amendment) Order (Northern Ireland) 2024

Citation, commencement and interpretation

1.—(1) This Order may be cited as the Misuse of Drugs (Designation) (Amendment) Order (Northern Ireland) 2024 and shall come into operation on 27th March 2024.

(2) The Interpretation Act (Northern Ireland) 1954(1) shall apply to this Order as it applies to an Act of the Northern Ireland Assembly.

Amendment of the Misuse of Drugs (Designation) Order (Northern Ireland) 2001

2.—(1) The following amendments are made to Part 1 of Schedule 1 to the Misuse of Drugs (Designation) Order (Northern Ireland) 2001(2) (which specifies Controlled Drugs to which section 7(4) of the Misuse of Drugs Act 1971 applies).

(2) In paragraph 1(a) —

(a) after “Bromazolam (8-bromo-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine)” insert “Brorphine”;

(b) after “1,4-Butanediol” insert “Butonitazene”;

(c) after “Clonazolam (6-(2-Chlorophenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4] benzodiazepine)” insert “Clonitazene”;

(d) after “Concentrate of poppy-straw” insert “Cumyl-PeGaClone”;

(e) after “Diclazepam (7-Chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one)” insert—

“Diphenidine

Ephenidine

Ethyleneoxynitazene”;

(f) after “Etizolam” insert—

“Etodesnitazene (etazene)

Etonitazene”;

(g) after “Flubromazolam (8-Bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4] benzodiazepine)” insert “Flunitazene”;

(h) after “Isopropylphenidate (IPP or IPPD)” insert “Isotonitazene”;

(i) after “Methcathinone” insert “Methoxyphenidine”;

(j) after “Metizolam (4-(2-Chlorophenyl)-2-ethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4] diazepine)” insert—

“Metodesnitazene (metazene)

Metonitazene”;

(k) after “Propylphenidate” insert “Protonitazene”;

(l) after “1-Cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45)” insert—

“N-Desethyl etonitazene

N-Desethylisotonitazene

N-Desethyl protonitazene”;

(m) after “4-Methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4’-DMAR)” insert—

“N-Piperidinyl-etonitazene (etonitazepipne)

N-Pyrrolidino-etonitazene (etoniazepyne)

N-Pyrrolidino protonitazene”.

Sealed with the Official Seal of the Department of Health on 6th March 2024.

(L.S.)

Cathy Harrison

A senior officer of the Department of Health